Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Beta-cell Autoimmunity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02000817
What this trial is testing

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 30
Not applicableUnknownNCT02117518
What this trial is testing

Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients

Who this might be right for
Type I Diabetes
Migal Galilee Research Institute 50
Early research (Phase 1)Ended earlyNCT01183468
What this trial is testing

A Research Trial of Aralast in New Onset Diabetes (RETAIN)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Study completedNCT03635437
What this trial is testing

Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Per-Ola Carlsson 35
Large-scale testing (Phase 3)Ended earlyNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Not applicableLooking for participantsNCT07666789
What this trial is testing

Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement

Who this might be right for
Type 1 Diabetes (T1D)Islets of Langerhans Transplantation
University Hospital, Montpellier 20
Testing effectiveness (Phase 2)Study completedNCT02293837
What this trial is testing

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusNew-onset Type 1 Diabetes MellitusT1DM+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 136
Testing effectiveness (Phase 2)Study completedNCT02814838
What this trial is testing

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Dompé Farmaceutici S.p.A 76
Not applicableUnknownNCT03106246
What this trial is testing

Circulating Extracellular Vesicles Released by Human Islets of Langerhans

Who this might be right for
Type1 Diabetes MellitusType2 DiabetesIslet Cell Transplantation
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Early research (Phase 1)Not Yet RecruitingNCT07610213
What this trial is testing

Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus (T1DM)Type 1 Diabetes MellitusAutoimmune Diabetes
Abdullah Kars 60
Testing effectiveness (Phase 2)Study completedNCT02372253
What this trial is testing

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Alabama at Birmingham 32
Testing effectiveness (Phase 2)Study completedNCT02803892
What this trial is testing

Monotherapy With Rapamycin in Long-standing Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Piemonti Lorenzo 55
Not applicableEnded earlyNCT03785275
What this trial is testing

Beta Cell Imaging in T1D Patients With a Different Glycemic Control

Who this might be right for
Type 1 Diabetes Mellitus
Radboud University Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT05742243
What this trial is testing

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
Melbourne Health 68
Not applicableStudy completedNCT01735123
What this trial is testing

Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity

Who this might be right for
Diabetes Mellitus, Type 1
University of Helsinki 87
Not applicableLooking for participantsNCT05139784
What this trial is testing

BeAT1D: Benign Autoimmunity and Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut National de la Santé Et de la Recherche Médicale, France 1,160
Very early researchUnknownNCT02284815
What this trial is testing

Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?

Who this might be right for
Diabetes Mellitus, Type 1
Herlev Hospital 20
Not applicableStudy completedNCT01825148
What this trial is testing

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

Who this might be right for
Type 1 Diabetes
Radboud University Medical Center 20
Not applicableStudy completedNCT01227538
What this trial is testing

Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University Hospitals Bristol and Weston NHS Foundation Trust 17
Not applicableUnknownNCT02871089
What this trial is testing

Closed Loop From Onset in Type 1 Diabetes

Who this might be right for
Diabetes MellitusType 1 Diabetes
University of Cambridge 96
Next Page